• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国住院儿童感染相关死亡率:一项2016年至2021年的多中心研究。

Infection-related mortality in hospitalized children: A multi-center study in China from 2016 to 2021.

作者信息

Tian Jiao, Li Qi, Cai Shiqi, Wang Xinyu, Ai Junhong, Feng Guoshuang, Zeng Yueping, Wang Ran, Xie Zhengde

机构信息

Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Beijing, China; Research Unit of Critical Infection in Children, 2019RU016, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory, Tianjin Children's Hospital, Tianjin, China.

Laboratory of Infection and Virology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China; Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Beijing, China; Research Unit of Critical Infection in Children, 2019RU016, Chinese Academy of Medical Sciences, Beijing, China; Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning, China.

出版信息

J Infect Public Health. 2025 Jun;18(6):102743. doi: 10.1016/j.jiph.2025.102743. Epub 2025 Mar 6.

DOI:
10.1016/j.jiph.2025.102743
PMID:40086142
Abstract

BACKGROUND

Hospitalized children experience mortality as a result of infections. Since the COVID-19 outbreak in early 2020, China's strict prevention measures have curbed pathogen transmission, altering infection-related epidemiology. The Futang Research Center of Pediatric Development has collected the face sheet of discharge medical records (FSMRs) data from 27 tertiary children's hospitals since January 2016, which facilitate us to investigate this issue. Moreover, this study focuses on hospitalized children aged 18 years old or younger.

METHODS

This study analyzed data from the FSMRs of children who died from infections at 27 tertiary children's hospitals across China between January 2016 and December 2021. Of these hospitals, 21 are located in provincial capitals. The data included gender, age, region, residence, year of admission, infections-associated causes of death, pathogens, length of stay, and expense.

RESULTS

A total of 1130 hospitalized children died from infections, accounting for 18.8 % of all deaths and 0.015 % of the total hospitalizations in the database during the period. Boys had a higher fatality than girls across different regions, age groups, years. Among all age groups, 0-28 days and 29 days-1 year group (≤365 days) had a higher number and proportion of deaths than other age groups. In terms of year of admission, the COVID-19 period (2020-2021) had a lower number of infections related death cases than pre-COVID-19 period. Further analysis of infection-related causes indicated that sepsis was the most common cause of death, followed by pneumonia, central nervous system infection, shock, enteritis, and myocarditis. The pathogens (bacterium, virus, fungus) were identified in 30.6 % of children.

CONCLUSIONS

Infections are the significant cause of death among hospitalized children in China.

摘要

背景

住院儿童会因感染而死亡。自2020年初新冠疫情爆发以来,中国严格的预防措施遏制了病原体传播,改变了与感染相关的流行病学情况。自2016年1月起,福棠儿童发展研究中心收集了27家三级儿童医院出院病历首页(FSMRs)数据,这有助于我们调查此问题。此外,本研究聚焦于18岁及以下的住院儿童。

方法

本研究分析了2016年1月至2021年12月期间中国27家三级儿童医院中因感染死亡儿童的FSMRs数据。这些医院中,21家位于省会城市。数据包括性别、年龄、地区、居住地、入院年份、感染相关死因、病原体、住院时长及费用。

结果

共有1130名住院儿童死于感染,占该时期数据库中所有死亡人数的18.8%,占总住院人数的0.015%。在不同地区、年龄组和年份中,男孩的死亡率高于女孩。在所有年龄组中,0 - 28天和29天至1岁组(≤365天)的死亡人数和比例高于其他年龄组。就入院年份而言,新冠疫情期间(2020 - 2021年)感染相关死亡病例数低于新冠疫情前时期。对感染相关病因的进一步分析表明,脓毒症是最常见的死因,其次是肺炎、中枢神经系统感染、休克、肠炎和心肌炎。30.6%的儿童中鉴定出了病原体(细菌、病毒、真菌)。

结论

感染是中国住院儿童死亡的重要原因。

相似文献

1
Infection-related mortality in hospitalized children: A multi-center study in China from 2016 to 2021.中国住院儿童感染相关死亡率:一项2016年至2021年的多中心研究。
J Infect Public Health. 2025 Jun;18(6):102743. doi: 10.1016/j.jiph.2025.102743. Epub 2025 Mar 6.
2
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
Inhaled corticosteroids for the treatment of COVID-19.吸入性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Mar 9;3(3):CD015125. doi: 10.1002/14651858.CD015125.